Tobacco Control Bill a ‘Transformative opportunity’ for Zambia’s cancer prevention

0
FB_IMG_1772178296081

Senior Medical Superintendent Dr. Susan Msandabwe (third right front row)

By Chapala Chikoyi
The Cancer Diseases Hospital (CDH) has described the Tobacco Control Bill NAB Number 40. of 2025 as a transformative opportunity for cancer prevention in Zambia.

Senior Medical Superintendent Dr. Susan Msandabwe (right).

In a comprehensive submission to the National Assembly Committee on Health, the hospital detailed how the proposed legislation could significantly reduce the escalating burden of tobacco-related cancers.
The hospital submitted that tobacco is implicated in at least 40 percent of all cancer diagnoses, with cancers of the oesophagus, colorectum, liver, and lung being major contributors to the mortality figures.
The hospital represented by Senior Medical Superintendent Dr. Susan Msandabwe told the committee that the Bill’s provisions directly support the National Cancer Control Strategic Plan for 2022 to 2026.

Senior Medical Superintendent Dr. Susan Msandabwe (right).

Dr. Msandabwe emphasized that comprehensive bans on advertising, smoke-free environments, and nationwide education campaigns will reduce tobacco initiation and promote cessation.
Dr. Msandabwe stressed that reduced cancer incidence would ease pressure on the country’s overstretched health infrastructure.
The team comprising Head of Clinical Care Dr. Paul Kamfwa and Dr. Aaron Shibemba, further revealed worrying trends in tobacco-associated cancers.

Senior Medical Superintendent Dr. Susan Msandabwe (third right front row).

They presented data showing a steady rise in cases of oesophageal, colorectal, and lung cancers between 2018 and 2022.
The health experts also warned that emerging nicotine products like e-cigarettes and heated tobacco are entering the Zambian market aggressively, targeting young people with flavoured options.
They called for such products to be included in the regulatory framework.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

绝妙集团公布50亿美元投资计划​作者:海伦·博瓦利亚(Hellen Bwalya)​绝妙集团有限公司(Wonderful Group of Companies Limited)通过其子公司赞比亚联合资本化肥有限公司(United Capital Fertilizer Zambia Company Limited),在其工业园区举行的奠基仪式上,正式启动了一项跨越2025年至2030年的50亿美元中长期工业投资宏伟计划。集团首席执行官黄耀弛先生在致答谢词时强调,该举措巩固了集团致力于提升赞比亚经济潜力、农业发展和就业水平的长期承诺。本次活动展示了多项价值数亿美元的制造业扩建及基础设施升级项目,旨在将赞比亚打造成中东非地区的核心工业强国。​在这项50亿美元的投资承诺中,园区内大规模的化工与化肥厂建设处于核心地位。继投资6.8亿美元的一期尿素生产厂竣工并投入运营后,集团正在稳步推进投资3.00亿美元的农化磷肥厂建设,预计将于第一季度投产,用于生产专用二铵(DAP)化肥。进一步的扩建计划还包括投资16亿美元的二期尿素项目和投资7.00亿美元的磷肥扩建项目,同时集团还将努力吸引更多绿色与高新技术投资者入驻运营。​为了支持这一工业增长并优化大宗运输物流,绝妙集团宣布了多项基础设施升级计划,包括升级连接当地矿山并穿过该工业园区的区域铁路网络、将蒙格维路(Mungwi Road)的部分路段改造为双向四车道,以及拓宽通往蒙布瓦路(Mumbwa Road)的连接线。这些基础设施项目将在完成内部财务手续后,通过政府与社会资本合作(PPP)模式实施,以畅通交通流量并缩短物资交付时间。黄耀弛先生对关键金融合作伙伴表达了谢意,向由艾莎银行(Absa Bank PLC)和赞比亚国家商业银行(ZANACO Bank PLC)牵头的银行银团为相关建设提供资金支持致以深切感谢。​在澄清公司身份时,黄耀弛先生指出,尽管早期外界存在误解,但绝妙集团和联合资本化肥公司均是值得骄傲的赞比亚本土企业。他强调,管理层中仅有两名中国籍员工,且均未直接参与日常运营,企业的行政控制权与管理权完全掌握在赞比亚本地人手中。黄耀弛先生重申了集团的承诺,并对赞比亚实现自产自销、对外出口以及引领东非和南部非洲工业未来的能力表达了坚定信心。